UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in OGN — Organon & Co.
CIK 861177
NEW YORK, NY
Position in OGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$10,046,798
+$5,381,161 QoQ
Shares Held
742,009
-4.7% QoQ
Ownership
0.283%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#47
of 626 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 43%
Shared 0%
None 57%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $25,598,342,767 across 16 Drug Manufacturers - General names. OGN ranks #12 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,209,385 | $8,647,153,365 | |
| 2 | JNJ |
Johnson & Johnson
|
18,416,123 | $4,677,142,752 | |
| 3 | ABBV |
AbbVie Inc.
|
14,267,697 | $3,590,323,267 | |
| 4 | MRK |
Merck & Co., Inc.
|
19,547,171 | $2,511,811,470 | |
| 5 | AMGN |
Amgen Inc
|
5,390,910 | $1,952,156,323 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
12,986,591 | $1,640,725,902 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
22,839,010 | $1,315,983,749 | |
| 8 | PFE |
Pfizer Inc
|
36,157,306 | $870,667,923 |
All Filings in OGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,046,798 | 742,009 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $4,665,637 | 778,905 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $5,762,015 | 803,629 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $8,512,317 | 797,034 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $11,557,227 | 1,193,929 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $15,530,132 | 1,042,991 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $15,163,951 | 1,016,351 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $16,000,115 | 836,389 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $17,229,847 | 832,360 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $8,639,932 | 459,571 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $6,737,179 | 467,211 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $8,997,058 | 518,264 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $13,667,338 | 656,768 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $15,447,179 | 656,768 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $17,980,909 | 643,785 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $14,575,270 | 622,875 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $23,306,632 | 690,567 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $22,637,500 | 648,082 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $18,959,688 | 622,650 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $19,491,684 | 594,440 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $17,525,923 | 579,178 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||